ASKG-712 (AM712) is a recombinant humanized monoclonal antibody (mAb) combined with an Ang-2 antagonist peptide fusion protein. It is utilized in research focused on wet age-related macular degeneration and diabetic macular edema.
Target:
VEGFR|||Tie-2
* VAT and and shipping costs not included. Errors and price changes excepted
